Meys E, Fontanges E, Fourcade N, Thomasson A, Pouyet M, Delmas P D
INSERM Research Unit 234, Hôpital Edouard Herriot, Lyons, France.
Am J Med. 1994 Nov;97(5):445-50. doi: 10.1016/0002-9343(94)90324-7.
We assessed changes in body composition and bone loss following liver transplantation to determine if bone loss is related to the underlying liver disease or to other factors such as sex, menopause, or graft rejection episodes.
Our cross-sectional study component compared bone mass and body composition in 31 patients at 1 year after liver transplantation versus 33 pregraft patients with chronic liver disease. Bone mass was measured by dual energy X-ray absorptiometry (DXA) using anteroposterior views of the total body to determine bone mineral content (BMC), and of the lumbar spine to assess bone mineral density (BMD). The body fat content was also determined by DXA. Radiographs of the thoracic and lumbar spine were also obtained. In our longitudinal study component, 16 patients from the pregraft group underwent bone mass assessment again 1 year after transplantation.
Graft patients and pregraft patients both had reduced lumbar spine BMD compared to age- and sex-matched normal values (P < 0.001). A 4.75% increase in body fat content was observed after liver transplantation (P < 0.05). In the cross sectional study, bone mass of the spine and total body were not different in pre- and posttransplantation patients. However, the longitudinal study revealed significant decreases in spinal BMD and total body BMC, with a mean 3.5% decrease and a rate of loss of 0.55% per month. In addition, a dramatically high prevalence (29%) of vertebral fractures was observed in grafted patients, contrasting with a low prevalence (8.4%) of fractures in pregraft patients. Menopause, primary biliary cirrhosis, and chronic alcohol abuse were the principal contributing factors for osteoporosis. Patients with vertebral fractures had a marked 17.4% decrease of the lumbar spine BMD (P < 0.001) and a 22% decrease in total BMC when compared to patients without fractures (P < 0.01).
Patients with orthotopic liver transplantation for chronic liver disease evaluated 1 year after transplantation have a high prevalence of vertebral fractures. Cross sectionally, bone mass was not different in patients before and after transplantation, but the longitudinal study showed that liver transplantation induced a marked and rapid bone loss. Bone loss due to transplantation could enhance the risk of new vertebral fractures, as shown by the high prevalence of vertebral fractures. These results emphasize the need to identify patients with low bone mass by bone densitometry before transplantation.
我们评估了肝移植后身体成分的变化和骨质流失情况,以确定骨质流失是否与潜在的肝脏疾病有关,或与其他因素如性别、绝经或移植排斥反应有关。
我们的横断面研究部分比较了31例肝移植术后1年患者与33例慢性肝病移植前患者的骨量和身体成分。采用双能X线吸收法(DXA)通过全身前后位片测量骨矿物质含量(BMC),通过腰椎前后位片评估骨矿物质密度(BMD)。身体脂肪含量也通过DXA测定。还获取了胸腰椎的X线片。在我们的纵向研究部分,移植前组的16例患者在移植后1年再次进行骨量评估。
与年龄和性别匹配的正常值相比,移植患者和移植前患者的腰椎BMD均降低(P < 0.001)。肝移植后观察到身体脂肪含量增加了4.75%(P < 0.05)。在横断面研究中,移植前后患者的脊柱和全身骨量没有差异。然而,纵向研究显示脊柱BMD和全身BMC显著下降,平均下降3.5%,每月丢失率为0.55%。此外,移植患者中椎体骨折的患病率极高(29%),而移植前患者骨折患病率较低(8.4%)。绝经、原发性胆汁性肝硬化和慢性酒精滥用是骨质疏松的主要促成因素。与无骨折患者相比,椎体骨折患者的腰椎BMD显著下降17.4%(P < 0.001),全身BMC下降22%(P < 0.01)。
慢性肝病原位肝移植患者在移植后1年评估时椎体骨折患病率很高。横断面研究显示,移植前后患者的骨量没有差异,但纵向研究表明肝移植导致明显且快速的骨质流失。如椎体骨折的高患病率所示,移植导致的骨质流失会增加新的椎体骨折风险。这些结果强调了在移植前通过骨密度测定识别低骨量患者的必要性。